Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg positive chronic hepatitis B naïve patients

2021 ◽  
Author(s):  
Jing Li ◽  
Lihong Qu ◽  
Xuehua Sun ◽  
Yanhong Liu ◽  
Qiming Gong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Tenofovir Disoproxil Fumarate ◽  
Hbsag Loss ◽  
Positive Chronic Hepatitis

Treatment with Peg-Interferon alpha-2b for HBeAg-Positive Chronic Hepatitis B: HBsAg Loss Is Associated with HBV Genotype

2006 ◽  
Vol 101 (2) ◽  
pp. 297-303 ◽  
Author(s):  
Hajo J. Flink ◽  
Monika van Zonneveld ◽  
Bettina E. Hansen ◽  
Robert A. de Man ◽  
Solko W. Schalm ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Hbv Genotype ◽  
Interferon Alpha 2B ◽  
Hbsag Loss ◽  
Positive Chronic Hepatitis

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

2018 ◽  
Vol 23 (8) ◽  
pp. 711
Author(s):  
George V Papatheodoridis ◽  
Eirini I Rigopoulou ◽  
Margarita Papatheodoridi ◽  
Kalliopi Zachou ◽  
Vassilios Xourafas ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Term Therapy ◽  
Hbsag Loss ◽  
Long Term Therapy ◽  
Negative Chronic Hepatitis

FRI-163-Reduced liver-related complications after 13 years of follow-up of interferon-alpha treatment for HBeAg-positive chronic hepatitis B: The ELITE-B study

2019 ◽  
Vol 70 (1) ◽  
pp. e460
Author(s):  
Hannah S.J. Choi ◽  
Margo J.H. van Campenhout ◽  
Cedric de Jong ◽  
Hanneke van Vuuren ◽  
Milan Sonneveld ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Interferon Alpha ◽  
Positive Chronic Hepatitis ◽  
Interferon Alpha Treatment

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

2020 ◽  
Author(s):  
Maria Pfefferkorn ◽  
Tina Schott ◽  
Stephan Böhm ◽  
Danilo Deichsel ◽  
Christin Felkel ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Hbsag Loss ◽  
Positive Chronic Hepatitis

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

2018 ◽  
Vol 23 (8) ◽  
pp. 677-685 ◽  
Author(s):  
George V Papatheodoridis ◽  
Eirini I Rigopoulou ◽  
Margarita Papatheodoridi ◽  
Kalliopi Zachou ◽  
Vassilios Xourafas ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Term Therapy ◽  
Hbsag Loss ◽  
Long Term Therapy ◽  
Negative Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document